Clinical Trial Update: Flu-Bu-Mel Conditioning Regimen for Myeloid Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Flu-Bu-Mel conditioning regimen for myeloid disease in patients undergoing allo-HSCT; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapse Rate After Allogeneic Hematopoietic Stem Cell Transplantation

Drugs mentioned

• Flu-Bu-Mel conditioning regimen

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Relapse Rate After Allo-HSCT | Phase 2 | Status: COMPLETED